Class III antiarrhythmic agents in cardiac failure: lessons from clinical trials with a focus on the grupo de estudio de la sobrevida en la insuficiencia cardiaca en Argentina (GESICA)

Autor: Doval, Hernan C *
Zdroj: In The American Journal of Cardiology 1999 84(9) Supplement 1:109-114
Databáze: ScienceDirect